Meropenem Venus Pharma

Medicinal product

(Invented) name

Meropenem Venus Pharma

Active substance (s)

Meropenemas

Strength

500 mg

Pharmaceutical form

milteliai injekciniam ar infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01DH02, Meropenem

Marketing authorisation holder

Venus Pharma GmbH, Vokietija

Date of authorisation

2021-04-07

Date of renewal

Documents

4718_4719 Meropenem Venus Pharma PL 2023 12 14.docx

4718_4719 Pakuotės lapelis 2023 12 14.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

PT/H/2293/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Flakone yra	1 vnt.
Meropenemas	500 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
106260	92361	1092361	flakonas	N10		Receptinis	LT/1/21/4718/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2021-04-07	Registruotas